The US Food and Drug Administration stresses in a new final guidance document that physicians discuss with patients the benefits and risks of using a laparoscopic power morcellator (LPM) to remove uterine fibroids.
“As part of shared decision-making, physicians should discuss the risks and benefits of all relevant treatment options with their patients...